Methoxyeugenol Protects Against Lung Inflammation and Suppresses Neutrophil Extracellular Trap Formation in an LPS-Induced Acute Lung Injury Model
Abstract Acute lung injury (ALI) is a life-threatening acute inflammatory disease with high rates of morbidity and mortality worldwide. 4-Allyl-2,6-dimethoxyphenol (methoxyeugenol), a phenylpropanoid from a synthetic source, exhibits strong anti-inflammatory activity, but its effects on the inflammation of ALI have not yet been reported. In our study, the anti-inflammatory effects of methoxyeugenol were investigated on RAW 264.7 cells and a mice model of ALI. Our results showed that methoxyeugenol (7.5 and 30 µM) attenuated the proliferation and gene expression of interleukin (IL)-6 in LPS-stimulated RAW 264.7 cells. In a mice model of ALI induced with LPS, methoxyeugenol exhibited a significant protective effect, based on influx reduction of macrophages and neutrophils into the lungs; reduction in release of the cytokines IL-6, TNF-α, and IL-10; and in reactive oxygen species (ROS) formation. We show that the anti-inflammatory effects of methoxyeugenol are associated with the suppression of the NFκB signaling pathway. Moreover, we demonstrated for the first time that a phenolic compound, from a synthetic source, protects against lung tissue inflammation and promotes a reduction of NET formation. These findings provided evidence for the use of methoxyeugenol as a new strategy to control inflammation in ALI disease..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Inflammation - 45(2022), 4 vom: 10. März, Seite 1534-1547 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Antunes, Géssica Luana [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 |
---|
doi: |
10.1007/s10753-022-01639-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR047273941 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR047273941 | ||
003 | DE-627 | ||
005 | 20230519065656.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220615s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10753-022-01639-8 |2 doi | |
035 | |a (DE-627)SPR047273941 | ||
035 | |a (SPR)s10753-022-01639-8-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Antunes, Géssica Luana |e verfasserin |0 (orcid)0000-0003-2172-5484 |4 aut | |
245 | 1 | 0 | |a Methoxyeugenol Protects Against Lung Inflammation and Suppresses Neutrophil Extracellular Trap Formation in an LPS-Induced Acute Lung Injury Model |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 | ||
520 | |a Abstract Acute lung injury (ALI) is a life-threatening acute inflammatory disease with high rates of morbidity and mortality worldwide. 4-Allyl-2,6-dimethoxyphenol (methoxyeugenol), a phenylpropanoid from a synthetic source, exhibits strong anti-inflammatory activity, but its effects on the inflammation of ALI have not yet been reported. In our study, the anti-inflammatory effects of methoxyeugenol were investigated on RAW 264.7 cells and a mice model of ALI. Our results showed that methoxyeugenol (7.5 and 30 µM) attenuated the proliferation and gene expression of interleukin (IL)-6 in LPS-stimulated RAW 264.7 cells. In a mice model of ALI induced with LPS, methoxyeugenol exhibited a significant protective effect, based on influx reduction of macrophages and neutrophils into the lungs; reduction in release of the cytokines IL-6, TNF-α, and IL-10; and in reactive oxygen species (ROS) formation. We show that the anti-inflammatory effects of methoxyeugenol are associated with the suppression of the NFκB signaling pathway. Moreover, we demonstrated for the first time that a phenolic compound, from a synthetic source, protects against lung tissue inflammation and promotes a reduction of NET formation. These findings provided evidence for the use of methoxyeugenol as a new strategy to control inflammation in ALI disease. | ||
700 | 1 | |a Matzenbacher, Lucas Strassburger |4 aut | |
700 | 1 | |a Costa, Bruna Pasqualotto |4 aut | |
700 | 1 | |a de Sousa Basso, Bruno |4 aut | |
700 | 1 | |a Levorse, Vitor Giancarlo Schneider |4 aut | |
700 | 1 | |a Antunes, Krist Helen |4 aut | |
700 | 1 | |a Costa-Ferro, Zaquer Suzana Munhoz |4 aut | |
700 | 1 | |a de Oliveira, Jarbas Rodrigues |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Inflammation |d New York, NY [u.a.] : Springer Science + Business Media B.V., 1975 |g 45(2022), 4 vom: 10. März, Seite 1534-1547 |w (DE-627)SPR013017675 |w (DE-600)2015610-8 |x 1573-2576 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2022 |g number:4 |g day:10 |g month:03 |g pages:1534-1547 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10753-022-01639-8 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 45 |j 2022 |e 4 |b 10 |c 03 |h 1534-1547 |